home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Anti-Cancer Drug Discovery and Development Summit  
  May 16, 2001

Biochemistry / Immunology

 
     
  Strategic Research Institute, 236 West 27th Street, 8th Floor, NY, NY 10001
June 11-12, 2001


ORGANIZED INTO 5 SECTIONS:
-NEW MOLECULAR TARGETS
-THERAPEUTIC ANTIBODIES
-APPLIED GENOMICS IN CANCER
-ANGIOGENIC ADVANCES
-NOVEL THERAPEUTICS
FEATURING:
Protein kinases as targets for novel anti-cancer agents
NOVARTIS
Molecular medicine and clinical development of a novel proteasome inhibitor in cancer
MILLENNIUM PHARMACEUTICALS
Application of genomics & proteomics to the development of diagnostics and therapeutics for cancer
CELERA GENOMICS
Identification of mitotic kinesin inhibitors as novel cancer therapeutics
CYTOKINETICS
 
 
Organized by: to register call 1-888-666-8514
Invited Speakers: chief scientists, medical advisors, senior researchers, and other associates
 
Deadline for Abstracts: abstracts have already been announced
 
Registration: to register call 1-888-666-8514
E-mail: www.esingleton@srinstitute.com
 
  Posted by:   EDRILON  
Host: 12.3.58.10
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.